Jemera, Resha Kate G.
HRN: 15-05-78 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/13/2024
CEFUROXIME 750MG (VIAL)
09/13/2024
09/19/2024
IVTT
733 Mg
Q8hrs
Pyelonephritis
Waiting Final Action
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes